Crown Electrokinetics Corp. Common Stock
CRKN
CRKN was delisted on the 4th of March, 2025.
1 hedge funds and large institutions have $265K invested in Crown Electrokinetics Corp. Common Stock in 2023 Q1 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 1 → 1 (0)
36% less capital invested
Capital invested by funds: $417K → $265K (-$151K)
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FIA
FNY Investment Advisers
New York
|
-$25K |
| 2 |
PTP
Platform Technology Partners
New York
|
-$18.9K |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$7.77K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$4.07K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
26
UBS Group
Zurich,
Switzerland
| – | -$4.07K | – | – |
|
CRKN Hedge Fund Activity: Q1 2023 in Review
1 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Crown Electrokinetics Corp. Common Stock (CRKN) for Q1 2023, worth a combined $265K — down 36% from $417K a quarter earlier.
Fund positioning in CRKN was balanced in Q1 2023: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.
The largest seller was FNY Investment Advisers, cutting an estimated $25K.
- 1 institutional investor held Crown Electrokinetics Corp. Common Stock (CRKN) as of Q1 2023, unchanged from Q4 2022.
- Funds reported $265K of Crown Electrokinetics Corp. Common Stock stock for Q1 2023, down 36% quarter-over-quarter.
- 0 funds opened new Crown Electrokinetics Corp. Common Stock positions in Q1 2023 and 0 closed out.
- The largest Crown Electrokinetics Corp. Common Stock seller in Q1 2023 was FNY Investment Advisers, an estimated $25K sold.
Based on aggregated 13F filings for Q1 2023.